Organization, Description of the Business and Liquidity (Details Narrative) - USD ($)										9 Months Ended	12 Months Ended	27 Months Ended
	Apr. 12, 2023	Apr. 03, 2023	Feb. 16, 2023	Feb. 16, 2023	Dec. 15, 2022	Dec. 15, 2022	Apr. 13, 2022	Apr. 12, 2022	Jun. 11, 2021	Sep. 30, 2022	Dec. 31, 2022	Sep. 30, 2023	Feb. 23, 2021
Accumulated deficit											$ 260,676,000	$ 272,465,000
Cash and cash equivalents											19,993,000	13,783,000
Marketable equity securities fair value											433,000	$ 441,000
Purchase of warrant												819,767
Severance cost	$ 300,000										$ 1,900,000
BTIG, LLC [Member]
Gross proceeds from offering												$ 6,270,000
Fair value of common stock sold												56,167
Sale of stock, price per share												$ 111.60
Common Stock [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares										1,314,000
Shares issued price per share							$ 0.20
Razor Stock Purchase Agreement [Member] | Common Stock [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares				1,366,364
Razor Stock Purchase Agreement [Member] | Common Stock [Member] | Dragon [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares						3,188,181
At The Market Sales Agreement [Member] | BTIG, LLC [Member]
Gross proceeds from offering									$ 50,000,000
Securities Purchase Agreement [Member] | Series A Redeemable Convertible Preferred Stock [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares							11,765
Issuance of Series A redeemable convertible preferred stock, net of financing costs, shares							384,477
Conversion price							$ 30.60
Underwriting Agreement [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares							196,998
Shares issued price per share							$ 24.85
Underwriting Agreement [Member] | Underwriter [Member] | Series A Redeemable Convertible Preferred Stock [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares								1,313,320
Purchase of warrant								1,313,320
Underwriting Agreement [Member] | Underwriter [Member] | Series A Redeemable Convertible Preferred Stock [Member] | Minimum [Member]
Purchase of warrant								656,660
Underwriting Agreement [Member] | Common Stock [Member]
Purchase of warrant							98,499
Registered Direct Offering [Member] | Maximum [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares		2,278,121
Registered Direct Offering [Member] | Board Members [Member]
Shares issued price per share		$ 7.08
Registered Direct Offering [Member] | Board Members [Member] | Maximum [Member]
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares		2,278,121
Registered Direct Offering [Member] | Other Investors [Member]
Shares issued price per share		$ 6.03
Razor Genomics, Inc. [Member]
Equity interest													25.00%
Dragon Scientific LLC [Member] | Razor Stock Purchase Agreement [Member]
Equity interest					70.00%	70.00%
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares					3,188,181
Razor [Member] | Razor Stock Purchase Agreement [Member]
Equity interest			30.00%	30.00%
Razor [Member] | Razor Stock Purchase Agreement [Member] | Common Stock [Member]
Equity interest			30.00%	30.00%
Issuance of common shares, including at-the-market transactions, net of financing costs and underwriting discounts, shares			1,366,364
Razor [Member] | Razor Stock Purchase Agreement [Member] | Common Stock [Member] | Dragon [Member]
Equity interest			70.00%	70.00%	70.00%	70.00%